Costimulatory and coinhibitory receptors in anti-tumor immunity
about
The PD-1 pathway in tolerance and autoimmunityPrimer on tumor immunology and cancer immunotherapyDendritic cell-based immunotherapy for glioma: multiple regimens and implications in clinical trialsGenetically modified T cells in cancer therapy: opportunities and challengesProspects of immune checkpoint modulators in the treatment of glioblastomaDendritic Cell-Based Immunotherapy Treatment for Glioblastoma MultiformeLow-Intensity Focused Ultrasound Induces Reversal of Tumor-Induced T Cell Tolerance and Prevents Immune Escape.Rational combinations of immunotherapeutics that target discrete pathways.Radiation-induced modulation of costimulatory and coinhibitory T-cell signaling molecules on human prostate carcinoma cells promotes productive antitumor immune interactionsImmune Checkpoint in Glioblastoma: Promising and ChallengingVaccines against human carcinomas: strategies to improve antitumor immune responses.IFN-γ upregulates survivin and Ifi202 expression to induce survival and proliferation of tumor-specific T cells.In situ vaccination combined with androgen ablation and regulatory T-cell depletion reduces castration-resistant tumor burden in prostate-specific pten knockout mice.Cytokine-Induced Killer Cells As Pharmacological Tools for Cancer Immunotherapy.ICOS gene polymorphisms are associated with sporadic breast cancer: a case-control studyMechanisms of costimulation.Immune inhibitory molecules LAG-3 and PD-1 synergistically regulate T-cell function to promote tumoral immune escapeThe tumor-immune microenvironment and response to radiation therapyRecent Insight into the Role of the PD-1/PD-L1 Pathway in Feto-Maternal Tolerance and Pregnancy.Clinical Implications of Co-Inhibitory Molecule Expression in the Tumor Microenvironment for DC Vaccination: A Game of Stop and Go.Immunomodulatory effects of polysaccharide from marine fungus Phoma herbarum YS4108 on T cells and dendritic cells.A common 56-kilobase deletion in a primate-specific segmental duplication creates a novel butyrophilin-like protein.Cancer immunotherapy and breaking immune tolerance: new approaches to an old challenge.Fusion protein of mutant B7-DC and Fc enhances the antitumor immune effect of GM-CSF-secreting whole-cell vaccineAssessment of variation in immunosuppressive pathway genes reveals TGFBR2 to be associated with prognosis of estrogen receptor-negative breast cancer after chemotherapyThe transcription factor MITF is a critical regulator of GPNMB expression in dendritic cells.PD-L1 Expression on Retrovirus-Infected Cells Mediates Immune Escape from CD8+ T Cell KillingReciprocity between Regulatory T Cells and Th17 Cells: Relevance to Polarized Immunity in Leprosy.CD28 family and chronic rejection: "to belatacept...And beyond!".Dendritic cell immunotherapy versus bevacizumab plus irinotecan in recurrent malignant glioma patients: a survival gain analysis.NFAT1 supports tumor-induced anergy of CD4(+) T cellsGenetic variation in the immunosuppression pathway genes and breast cancer susceptibility: a pooled analysis of 42,510 cases and 40,577 controls from the Breast Cancer Association ConsortiumProgrammed death 1 protects from fatal circulatory failure during systemic virus infection of mice.Serum-derived exosomes from mice with highly metastatic breast cancer transfer increased metastatic capacity to a poorly metastatic tumorB7-H3 and B7-H4 are independent predictors of a poor prognosis in patients with pancreatic cancerRecent advances and future of immunotherapy for glioblastoma.Co-expression of CD40L with CD70 or OX40L increases B-cell viability and antitumor efficacy.Interaction between tumour-infiltrating B cells and T cells controls the progression of hepatocellular carcinomaMechanisms of T-cell inhibition: implications for cancer immunotherapy.Design of vaccine adjuvants incorporating TNF superfamily ligands and TNF superfamily molecular mimics.
P2860
Q24633549-1E984C32-7FFB-4DC8-B936-CE6D86BE362BQ27001126-027CFEE9-4351-4305-A024-252644889D63Q27014829-1397598E-55D9-4D9C-ADF3-620F1C8B7597Q27026627-853F702F-AFE0-4702-A901-6B70D7D027EDQ28081371-C79C0C88-43FB-4A60-A10F-57DDDA26A0F8Q28087485-186AF2BD-F24D-4B18-B2BB-4D4EAA1330C2Q30363260-85D5FAEE-B863-4CB9-B23F-C2F6DE9A98E9Q33606144-57DEB642-7A4B-444B-9B0D-AC7BAACD3446Q33627023-C8A77982-8895-4F6D-AFAB-F5A4E5C5D4E7Q33650058-0626EA35-3511-428F-A4EF-58A5CE5F9FD9Q33734281-8CBB3921-94BD-4E8D-BD84-3447BA2C49F5Q33761188-16601B72-1067-4158-93DC-E2CF35E33FA5Q33837085-AF03138B-48E0-4223-BC7D-3AC567004861Q33875615-D46473FD-A366-4BF5-99C2-871B9C53DBF0Q34019536-B8FE047C-D9BE-4740-92A6-6F0C68FF0419Q34085850-922A2230-E883-43B1-8530-FA3504C2878EQ34241893-6BC54040-CA30-44E7-ACD5-EFE31C03BBFAQ34444598-C9312F88-33FE-457D-BC4B-567873960382Q34460789-0D90B7B5-A2BE-4AAB-9857-A3A12164E41BQ34658452-62694390-1FA1-4CA6-BFE1-D44678974221Q34707229-659C620F-9633-45BD-AA2E-561538EC6F50Q34799886-2D0D50FF-BC71-47DE-98A9-83804DE25DAFQ34859794-69585DC7-56A4-43F2-B91E-C8EDD4442335Q35130450-4184259D-2366-4151-8DD1-EF36CA4758EEQ35218520-C25AE6F5-E728-4D99-8581-E1F1792B1E5AQ35608944-EA393D9A-5463-483B-9E0D-CF9D6BA4DF4AQ35814368-DC4E6008-1868-453F-95D6-8120CE94C913Q35890068-549E7550-78CD-478F-890F-3B413A7BD64CQ36037639-D31161D5-1B4B-4894-9A41-1DB6BF8D5148Q36201736-D3811668-92D3-42BC-9300-43D6E97E9BE9Q36243594-B3043D82-55C4-4ED3-A30F-AFE8F307486CQ36422109-38C9F803-A578-40B8-A9F5-2B7D918EA79BQ36478253-492F7A83-9C71-4D50-976A-A8FFA2939B3EQ36528333-71957226-47DA-47EA-B73B-DCCFB90E7E73Q36640287-3F5C60C3-8577-4215-BFC9-D06615FA5335Q37239071-F0B907E5-DDDD-4E1A-A089-794DD05324E2Q37564683-B41CD9BA-9138-492D-865B-E9CD5F95F896Q37617052-8AF31E1E-E75C-4D08-9BF2-29D9047EDC9DQ37658886-89CE2F93-26B1-4BCD-A4AE-7F3CB240F4EAQ37668114-21840C7A-EE5B-46F2-94E6-AD280A23FA3C
P2860
Costimulatory and coinhibitory receptors in anti-tumor immunity
description
article científic
@ca
article scientifique
@fr
articolo scientifico
@it
artigo científico
@pt
bilimsel makale
@tr
scientific article published on May 2009
@en
vedecký článok
@sk
vetenskaplig artikel
@sv
videnskabelig artikel
@da
vědecký článek
@cs
name
Costimulatory and coinhibitory receptors in anti-tumor immunity
@en
Costimulatory and coinhibitory receptors in anti-tumor immunity.
@nl
type
label
Costimulatory and coinhibitory receptors in anti-tumor immunity
@en
Costimulatory and coinhibitory receptors in anti-tumor immunity.
@nl
prefLabel
Costimulatory and coinhibitory receptors in anti-tumor immunity
@en
Costimulatory and coinhibitory receptors in anti-tumor immunity.
@nl
P2093
P2860
P1476
Costimulatory and coinhibitory receptors in anti-tumor immunity
@en
P2093
Gregory Driessens
Justin Kline
Thomas F Gajewski
P2860
P304
P356
10.1111/J.1600-065X.2009.00771.X
P577
2009-05-01T00:00:00Z